Procter & Gamble Co. said its normalized net income for the fiscal fourth quarter ended June 30 amounted to 67 cents per share, compared with the S&P Capital IQ consensus estimate of 95 cents per share.

EPS declined 16.8% year over year from 80 cents.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $2.04 billion, a decline of 11.8% from $2.32 billion in the prior-year period.

Total revenue fell 9.2% year over year to $17.79 billion from $19.60 billion, and total operating expenses fell 5.4% from the prior-year period to $14.83 billion from $15.68 billion.

Reported net income declined 75.2% year over year to $623.0 million, or 20 cents per share, from $2.52 billion, or 87 cents per share.

For the year, the company's normalized net income totaled $3.11 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $3.97.

EPS rose 10.1% from $2.83 in the prior year.

Normalized net income was $8.97 billion, a rise of 9.3% from $8.21 billion in the prior year.

Full-year total revenue increased on an annual basis to $76.28 billion from $74.40 billion, and total operating expenses increased on an annual basis to $61.41 billion from $60.49 billion.

The company said reported net income decreased 16.1% on an annual basis to $8.82 billion, or $3.06 per share, in the full year, from $10.52 billion, or $3.62 per share.